Triglycerides and Cardiovascular Disease
2011/04/19 by Michael Miller, Neil J. Stone, Christie M. Ballantyne +16 · 33 citations
Medicine · Nursing · #Diabetes, Cardiovascular Risks, and Lipoproteins #Diet, Metabolism, and Disease #Fatty Acid Research and Health
paper · pdf · doi:10.1161/cir.0b013e3182160726
Abstract
The American Heart Association makes every effort to avoid any actual or potential conflicts of interest that may arise as a result of an outside relationship or a personal, professional,
Citations
Cited by
- 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
- Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease
- Relationship of the triglyceride to high-density lipoprotein cholesterol (TG/HDL-C) ratio to the remainder of the lipid profile: The Very Large Database of Lipids-4 (VLDL-4) study
- Global genetic diversity of human apolipoproteins and effects on cardiovascular disease risk
- Association of Elevated Triglycerides With Increased Cardiovascular Risk and Direct Costs in Statin-Treated Patients
- Obesity due to MC4R deficiency is associated with reduced cholesterol, triglycerides and cardiovascular disease risk
- Serum Lipid Profiles and Cholesterol-Lowering Medication Use in Relation to Subsequent Risk of Colorectal Cancer in the UK Biobank Cohort
- 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD
- The role of triglycerides in atherosclerosis. [europepmc]
- Mutations in LPL, APOC2, APOA5, GPIHBP1 and LMF1 in patients with severe hypertriglyceridaemia. [europepmc]
- Nonalcoholic fatty liver disease and serum lipoproteins: the Multi-Ethnic Study of Atherosclerosis. [europepmc]
- How do elevated triglycerides and low HDL-cholesterol affect inflammation and atherothrombosis? [europepmc]
- Common variants associated with plasma triglycerides and risk for coronary artery disease. [europepmc]
- Racial/ethnic differences in dyslipidemia patterns. [europepmc]
- Loss-of-function mutations in APOC3, triglycerides, and coronary disease. [europepmc]
- Targeting inflammation in metabolic syndrome. [europepmc]
- Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association. [europepmc]
- Inactivating Variants in ANGPTL4 and Risk of Coronary Artery Disease. [europepmc]
- Metabolomic Profiling of Statin Use and Genetic Inhibition of HMG-CoA Reductase. [europepmc]
- Fasting-mimicking diet and markers/risk factors for aging, diabetes, cancer, and cardiovascular disease. [europepmc]
- Omega-3 Polyunsaturated Fatty Acid (Fish Oil) Supplementation and the Prevention of Clinical Cardiovascular Disease: A Science Advisory From the American Heart Association. [europepmc]
- Mono-unsaturated fatty acids link H3K4me3 modifiers to C. elegans lifespan. [europepmc]
- Gut Microbiota-Dependent Trimethylamine-N-oxide and Serum Biomarkers in Patients with T2DM and Advanced CKD. [europepmc]
- Hypertriglyceridemia and atherosclerosis. [europepmc]
- The Forgotten Lipids: Triglycerides, Remnant Cholesterol, and Atherosclerotic Cardiovascular Disease Risk. [europepmc]
- 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. [europepmc]
- Association Between Triglyceride Lowering and Reduction of Cardiovascular Risk Across Multiple Lipid-Lowering Therapeutic Classes: A Systematic Review and Meta-Regression Analysis of Randomized Controlled Trials. [europepmc]
- Prevalence and risk factors for dyslipidemia among adults in rural and urban China: findings from the China National Stroke Screening and prevention project (CNSSPP). [europepmc]
- Ten-Hour Time-Restricted Eating Reduces Weight, Blood Pressure, and Atherogenic Lipids in Patients with Metabolic Syndrome. [europepmc]
- Remnants of the Triglyceride-Rich Lipoproteins, Diabetes, and Cardiovascular Disease. [europepmc]
- Causes and Consequences of Hypertriglyceridemia. [europepmc]
- Remnant cholesterol predicts cardiovascular disease beyond LDL and ApoB: a primary prevention study. [europepmc]
- Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies-a consensus statement from the European Atherosclerosis Society. [europepmc]
Related